Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 39 results:
Author Title Type [ Year] Filters: Author is Akriviadis, Evangelos [Clear All Filters]
(2021).
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?.
Ann Hepatol. 19(2), 134-144.
(2020). Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis..
Clin Gastroenterol Hepatol. 17(9), 1744-1755.e11.
(2019). The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis..
Eur J Gastroenterol Hepatol. 31(7), 897-898.
(2019). Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials..
Gastroenterology. 155(2), 458-468.e8.
(2018). Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature..
Clin Mol Hepatol. 24(3), 345-349.
(2018). Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis..
J Gastroenterol Hepatol. 32(1), 191-198.
(2017). High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis..
Ann Gastroenterol. 30(2), 217-224.
(2017). Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study..
Dig Dis Sci. 62(5), 1363-1372.
(2017). Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).
(2017). Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels..
Ann Gastroenterol. 29(2), 208-13.
(2016). Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain..
Liver Transpl. 22(1), 132-3.
(2016). Treatment of alcoholic hepatitis: is this a "dead-end"?.
Ann Gastroenterol. 29(2), 236-7.
(2016). Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients..
Ann Gastroenterol. 28(3), 374-378.
(2015). Authors' reply..
Ann Gastroenterol. 28(4), 507.
(2015). Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience..
Ann Gastroenterol. 28(4), 481-6.
(2015). Focal nodular hyperplasia in an individual with Abernethy malformation type 1b..
Dig Liver Dis. 47(12), 1089.
(2015). The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis..
Ann Gastroenterol. 28(1), 109-117.
(2015). Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis..
Rheumatol Int. 35(11), 1913-6.
(2015). On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients..
Liver Int. 35(5), 1540-8.
(2015). Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis..
Ann Gastroenterol. 28(1), 118-123.
(2015). Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy..
J Hepatol. 60(1), 62-8.
(2014). Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience..
Hepatol Int. 8(1), 137-45.
(2014). Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis..
Hepatol Res. 44(10), E145-55.
(2014).